Clinical Trials Logo
  1. Home
  2. Erythema Migrans
  3. NCT03980015

Inflammatory Responses in Solitary and Multiple Erythema Migrans

Erythema Migrans Clinical Trial

Official title:
Inflammatory Responses in Borrelia Afzelii Culture Positive Patients With Early Disseminated or Early Localized Lyme Borreliosis

Clinical Trial Summary

The investigators will evaluate differences in host immune responses (levels of cytokines and chemokines, representative of innate, Th1, and Th17 immune responses) in acute sera from adult patients with solitary or multiple erythema migrans.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03980015
Study type Observational
Source University Medical Centre Ljubljana
Contact
Status Completed
Phase
Start date June 1, 2006
Completion date May 31, 2019
View Details
See also
  Status Clinical Trial Phase
Completed NCT01368341 - Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice Phase 4
Completed NCT01518192 - Comparison of Doxycycline and Cefuroxime Axetil for Treatment of Erythema Migrans: Clinical and Microbiological Outcome Phase 4
Recruiting NCT03966014 - Different Amoxicillin Treatment Regimens in Erythema Migrans Patients N/A
Recruiting NCT03462329 - Patient's Pretreatment Expectations About Post-Lyme Symptoms N/A
Completed NCT03956212 - Inflammatory Mediators in Erythema Migrans N/A
Completed NCT03505879 - Next Generation Sequencing Detection of Lyme Disease
Recruiting NCT02147249 - Cytokines and Chemokines in Erythema Migrans N/A
Completed NCT02145754 - Culture Media for Borrelia Burgdorferi Sensu Lato N/A
Completed NCT03371563 - Erythema Migrans in Elderly
Completed NCT02414789 - Lyme Borreliosis and Early Cutaneous Diagnostic N/A
Completed NCT00132327 - Analysis of Lyme Disease Lesions